Listen to Melissa Fellner's Podcast Episode on Rare Diseases

February 26th 2026

Being a pioneer in the rare disease space poses unique challenges. Patient groups are often small; understanding is limited and clinical data is often lacking. Real transformation demands collaboration at its core – this is highlighted by AOP Health’s Melissa Fellner, Vice President Global Therapeutic Areas, in a new podcast episode with Pharmaphorum.

Listen to the conversation.

Pharmaphorum's podcast episode
with Melissa Fellner here.

New podcast with Pharmaphorum featuring AOP Health’s Melissa Fellner

AOP Health joins Pharmaphorum in a Rare Disease Day special exploring the evolving rare disease landscape and the role AOP Health’s 30-year heritage plays in shaping its future.

Within the episode, Mellissa reflects on what has motivated her to pursue a career in rare disease, how the diagnostic and treatment landscape has evolved, and the importance of partnership and collaboration in bringing innovative therapies to patients who need them the most. She also shares her excitement for what the future holds within rare disease.

AOP Health Vice President Global Therapeutic Areas

Progress in rare disease is real but only happens when we work together. If we continue to collaborate openly, share knowledge and keep patients at the centre of every decision, we can turn scientific outcomes into meaningful outcomes.

About AOP Health

AOP Health is a global enterprise group with roots in Austria, where the headquarters of AOP Orphan Pharmaceuticals GmbH ("AOP Health") is located. Since 1996, the AOP Health Group has been dedicated to developing innovative solutions to address unmet medical needs, particularly in the fields of rare diseases and intensive care medicine. The group has established itself internationally as a pioneer in integrated therapy solutions and operates worldwide through subsidiaries, representations, and a strong network of partners. With the claim "Needs. Science. Trust." the AOP Health Group emphasizes its commitment to research and development, as well as the importance of building relationships with physicians and patient advocacy groups to ensure that the needs of these stakeholders are reflected in all aspects of the company’s actions. (aop-health.com)

Press Contact.

Mag. Nina Roth, MAS

Head of Corporate Communications
nina.roth[at]aop-health.com

Needs. Science. Trust.

As a privately owned company, AOP Health is devoted to long-term commitment, high quality, and continuity. For a small number of very special diseases the company is sole supplier of some key therapeutic agents throughout the world.